One of the most exciting technologies to come along in recent times is that of nanotechnology. According to Wikipedia, the online encyclopedia, nanotechnology actually encompasses diverse lines of inquiry. Nanotechnology cuts across many disciplines, including colloidal science, chemistry, applied physics, biology. It could variously be seen as an extension of existing sciences into the nanoscale, or as a recasting of existing sciences using a newer, more modern term.
NanoViricides, Inc. is working in the general field of Nanomedicine. This too is a very diverse field and encompasses a wide range of materials and applications. Specifically, we are working in the area of targeted anti-viral therapeutics. Utilizing nanoscale materials and processes licensed from TheraCour Pharma, Inc., we are developing anti-viral drugs against a wide range range of human and animal viruses.
NanoViricides, Inc. is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricides™) to advance the care of patients suffering from life-threatening viral infections. We are a development stage company.
Click here to download the NanoViricides, Inc. 2007 Calendar Year Summary
by the CEO, Dr. Eugene Seymour [pdf]
Click here to read the nanomedicine chapter from Jain BioPharma's market report on antivirals.
Click here for news about NanoViricides' move to NASD's OTC Bulletin Board
Click here to see NanoViricides Dismantling a Virus
